The table below shows GoodRx Holdings, Inc.'s cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q1 2025
Q1 2024
Q1 2023
Q1 2022
Q1 2021
Operating cash flow
$11.84M
$9.41M
$42.59M
$32.29M
$30.12M
$45.48M
Capital expenditure
$1.14M
$142.00K
$407.00K
$148.00K
$1.74M
$2.71M
Investing cash flow
-$21.64M
-$51.88M
-$20.61M
-$14.29M
-$34.40M
-$9.70M
Dividends paid
-
-
-
-
GDRX operating cash flow (10-K history)
GoodRx Holdings, Inc. reported operating cash flow of $167.90M for fiscal year 2025. That is down 8.7% from $183.89M in fiscal 2024. Over the 8 fiscal years shown, operating cash flow grew from $45.25M (FY 2018) to $167.90M. Figures come from the company's audited annual reports as filed with the SEC.
